To comply with Centers for Medicare and Medicaid Services (CMS) requirements, how often must a pharmacist conduct a Drug Regimen Review for long-term care patients?

A pharmacist must conduct a Drug Regimen Review for long-term care patients at least once a month to comply with CMS requirements. This federal requirement is designed to ensure the safety and efficacy of the medications being administered to residents in long-term care facilities. The monthly review allows pharmacists to assess medication regimens for potential drug interactions, therapeutic duplication, and appropriateness of dosages, ensuring optimal patient care.

Having a frequency of at least once a month helps address any issues promptly and supports the health and well-being of patients who may have complex medication needs. This process is essential to identify and mitigate any risks associated with polypharmacy, which is common in this population.

Other options, such as conducting reviews daily, weekly, or every six months, do not align with the established CMS requirement for long-term care facilities and would not provide the necessary oversight to adequately manage patient medication regimens. Regular interaction and assessment are key in preventing medication-related problems, and a monthly review strikes a balance between providing thorough oversight and managing the workload effectively.